The Effect of Vitamin D Supplementation on COVID-19 Recovery

• Status: Completed
• Trial end date: 2020-10-31
• Target enrollment: 0
• Participant gender: All

Summary

The COVID-19 caused by SARS-CoV-2 has transmitted quickly as a global public health emergency. The median duration for Sars-CoV-2 carrying in COVID-19 patients was 20 days (IQR 16-28) What is the role of vitamin D supplementation on the recovery time of asymptomatic and pauci-symptomatic COVID-19 subjects? the intervention group will have vitamin D supplementation (200,000 IU / 1 ml of Cholecalciferol (1 ml) Oral form). Control group will have a placebo treatment (physiological saline).

the negative RT-PCR date will be compared in the two groups

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Monastir
• Collaborators: Cyrine Ben Nasrallah; Hela Abroug; Imen Zemni; Loussaief Chawki; Manel Ben Belgacem; Manel Ben fredj; Nissaf Ben Alaya; Wafa Dhouib
• Treatments: Pharmaceutical Solutions; Plasma-lyte 148

Criteria

Inclusion Criteria:

• patients with COVID 19 and having a positive RT-PCR at control in

• 14 days from confirmation of infection for asymptomatic subjects and

• 7 days after the disappearance of symptoms for pauci-symptomatic subjects

Non inclusion Criteria: Pregnant women and children under the age of 18 will not be included

Exclusion Criteria:

• None